Amgen and Roche collaborate on cancer immunotherapy study with talimogene laherparepvec and atezolizumab
2 June 2015 | By Victoria White
Amgen and Roche are to collaborate on a study to evaluate talimogene laherparepvec in combination with atezolizumab in patients with cancer...